The retinitis pigmentosa GTPase regulator (RPGR) interacts with novel transport-like proteins in the outer segments of rod photoreceptors - PubMed (original) (raw)

. 2000 Sep 1;9(14):2095-105.

doi: 10.1093/hmg/9.14.2095.

Affiliations

• PMID: 10958648
• DOI: 10.1093/hmg/9.14.2095

The retinitis pigmentosa GTPase regulator (RPGR) interacts with novel transport-like proteins in the outer segments of rod photoreceptors

R Roepman et al. Hum Mol Genet. 2000.

Abstract

Mutations in the retinitis pigmentosa GTPase regulator (RPGR) gene cause X-linked retinitis pigmentosa type 3 (RP3), a severe, progressive and degenerative retinal dystrophy eventually leading to complete blindness. RPGR is ubiquitously expressed, yet mutations in the RPGR gene lead to a retina-restricted phenotype. To date, all RP3 associated missense mutations that have been identified are located in the RCC1-homologous domain (RHD) of RPGR. To investigate the molecular pathogenesis of RP3, we screened retinal yeast two-hybrid libraries with the RHD of RPGR. We identified several alternatively spliced gene products, some with retina-restricted expression, that interact specifically with RPGR in vivo and in vitro. Thus, these proteins were named RPGR-interacting protein 1 (RPGRIP1) isoforms. They contain a C-terminal RPGR-interacting domain and stretches of variable coiled-coil domains homologous to proteins involved in vesicular trafficking. The interaction between RPGR and RPGRIP1 isoforms was impaired in vivo by RP3-associated mutations in RPGR. Moreover, RPGR and RPGRIP1 co-localize in the outer segment of rod photoreceptors, which is in full agreement with the retinitis pigmentosa phenotype observed in RP3 patients. The localization of RPGRIP1 at 14q11 makes it a strong candidate gene for RP16. These results provide a clue for the retina-specific pathogenesis in RP3, and hint towards the involvement of RPGR and RPGRIP1 in mediating vesicular transport-associated processes.

PubMed Disclaimer

Similar articles

• Species-specific subcellular localization of RPGR and RPGRIP isoforms: implications for the phenotypic variability of congenital retinopathies among species.
  Mavlyutov TA, Zhao H, Ferreira PA. Mavlyutov TA, et al. Hum Mol Genet. 2002 Aug 1;11(16):1899-907. doi: 10.1093/hmg/11.16.1899. Hum Mol Genet. 2002. PMID: 12140192
• Identification of a novel protein interacting with RPGR.
  Boylan JP, Wright AF. Boylan JP, et al. Hum Mol Genet. 2000 Sep 1;9(14):2085-93. doi: 10.1093/hmg/9.14.2085. Hum Mol Genet. 2000. PMID: 10958647
• The retinitis pigmentosa GTPase regulator, RPGR, interacts with the delta subunit of rod cyclic GMP phosphodiesterase.
  Linari M, Ueffing M, Manson F, Wright A, Meitinger T, Becker J. Linari M, et al. Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1315-20. doi: 10.1073/pnas.96.4.1315. Proc Natl Acad Sci U S A. 1999. PMID: 9990021 Free PMC article.
• Mutations of RPGR in X-linked retinitis pigmentosa (RP3).
  Vervoort R, Wright AF. Vervoort R, et al. Hum Mutat. 2002 May;19(5):486-500. doi: 10.1002/humu.10057. Hum Mutat. 2002. PMID: 11968081 Review.
• RPGRIP1 is mutated in Leber congenital amaurosis: a mini-review.
  Koenekoop RK. Koenekoop RK. Ophthalmic Genet. 2005 Dec;26(4):175-9. doi: 10.1080/13816810500374441. Ophthalmic Genet. 2005. PMID: 16352478 Review.

Cited by

• Replacement gene therapy with a human RPGRIP1 sequence slows photoreceptor degeneration in a murine model of Leber congenital amaurosis.
  Pawlyk BS, Bulgakov OV, Liu X, Xu X, Adamian M, Sun X, Khani SC, Berson EL, Sandberg MA, Li T. Pawlyk BS, et al. Hum Gene Ther. 2010 Aug;21(8):993-1004. doi: 10.1089/hum.2009.218. Hum Gene Ther. 2010. PMID: 20384479 Free PMC article.
• Nephronophthisis: disease mechanisms of a ciliopathy.
  Hildebrandt F, Attanasio M, Otto E. Hildebrandt F, et al. J Am Soc Nephrol. 2009 Jan;20(1):23-35. doi: 10.1681/ASN.2008050456. Epub 2008 Dec 31. J Am Soc Nephrol. 2009. PMID: 19118152 Free PMC article. Review.
• RPGR protein complex regulates proteasome activity and mediates store-operated calcium entry.
  Patnaik SR, Zhang X, Biswas L, Akhtar S, Zhou X, Kusuluri DK, Reilly J, May-Simera H, Chalmers S, McCarron JG, Shu X. Patnaik SR, et al. Oncotarget. 2018 May 1;9(33):23183-23197. doi: 10.18632/oncotarget.25259. eCollection 2018 May 1. Oncotarget. 2018. PMID: 29796181 Free PMC article.
• Mutations in the X-linked retinitis pigmentosa genes RPGR and RP2 found in 8.5% of families with a provisional diagnosis of autosomal dominant retinitis pigmentosa.
  Churchill JD, Bowne SJ, Sullivan LS, Lewis RA, Wheaton DK, Birch DG, Branham KE, Heckenlively JR, Daiger SP. Churchill JD, et al. Invest Ophthalmol Vis Sci. 2013 Feb 19;54(2):1411-6. doi: 10.1167/iovs.12-11541. Invest Ophthalmol Vis Sci. 2013. PMID: 23372056 Free PMC article.
• Retinitis Pigmentosa GTPase Regulator (RPGR) protein isoforms in mammalian retina: insights into X-linked Retinitis Pigmentosa and associated ciliopathies.
  He S, Parapuram SK, Hurd TW, Behnam B, Margolis B, Swaroop A, Khanna H. He S, et al. Vision Res. 2008 Feb;48(3):366-76. doi: 10.1016/j.visres.2007.08.005. Epub 2007 Sep 27. Vision Res. 2008. PMID: 17904189 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • BioCyc
  • GlyGen glycoinformatics resource
  • The Weizmann Institute of Science GeneCards and MalaCards databases

• Research Materials

  • NCI CPTC Antibody Characterization Program